Apollo Hospitals had quietly acquired cancer-care aggregator Onco.com in December 2024, an Inc42 report stated.
The acquisition has dispelled recent speculations about the start-up's closure.
Financial terms of the deal were not disclosed, but Apollo reportedly plans to inject fresh capital and integrate Onco’s digital platform into its broader oncology services.
Apollo Hospitals has not officially commented on the purchase. However, the report states that Onco.com will be rebuilt under the Apollo brand as part of its expanding oncology roadmap, with additional funding allocated to scale the platform’s reach and capabilities.
Following the sale, co‑founder Jain has turned her attention to Marvix AI, a US‑headquartered, GenAI‑driven start-up that automates administrative workflows for clinicians, including an ambient AI scribe that generates finished clinical notes from physician‑patient consultations. Dr. Jotwani, meanwhile, has returned to clinical practice at Medicover Hospitals in Hyderabad.
With Apollo’s acquisition, Onco’s digital cancer‑care expertise is poised to be woven into one of India’s largest hospital networks, reflecting a broader trend of established healthcare providers snapping up niche telemedicine and digital‑health ventures to broaden their service offerings.
The acquisition coincides with Apollo Group’s ongoing demerger of its pharmacy distribution and digital‑health arm, Apollo HealthCo. That split will spin off Apollo’s omnichannel pharmacy network and its Apollo 24/7 digital platform into a separate entity, Apollo Healthtech, which is expected to announce the Onco transaction once the reorganisation is finalised.
Founded in 2016 by entrepreneur Rashie Jain and Dr. Amit Jotwani, Onco.com provided cancer patients with personalised, scientifically vetted guidance by connecting them to global oncologists, treatment centres and diagnostic labs.
Backed by investors including Accel, Rainmatter and Alteria Capital, the platform once attracted over 25,000 monthly visitors and generated more than 1,000 organic leads. Despite this traction, Onco’s founders posted in mid‑2024 that partnership talks with hospitals had stalled only for Apollo to complete a stealth acquisition six months later, according to the people familiar with the transaction.
